Related Experiment Videos
Cutaneous gene transfer and therapy: the present and the future
F Spirito1, G Meneguzzi, O Danos
1INSERM U385 Faculté de Médecine, Nice, France.
The Journal of Gene Medicine
|March 28, 2001
Summary
Skin gene therapy shows promise for treating genetic skin diseases and metabolic disorders by correcting faulty genes in skin cells. This approach could lead to new treatments for conditions like epidermolysis bullosa and ichthyosis.
Area of Science:
- Dermatology
- Genetics
- Molecular Biology
Background:
- The skin's accessibility makes it a viable target for gene therapy.
- Gene therapy has shown success in treating genetic skin disorders like epidermolysis bullosa and ichthyosis.
- Potential for treating metabolic disorders through skin-based gene therapy.
Purpose of the Study:
- To explore the potential of gene therapy for cutaneous and metabolic diseases.
- To evaluate the efficacy of gene correction in skin cells.
- To outline future directions for clinical applications.
Main Methods:
- Gene transfer into cultured skin cells using retroviral vectors.
- Correction of genetic defects in keratinocytes.
- Ex vivo reconstruction of artificial epithelia for transplantation.
Main Results:
- Successful phenotypic reversion in vivo for junctional epidermolysis bullosa and ichthyosis.
- Successful phenotypic reversion in vitro for xeroderma pigmentosum.
- Promising results in correcting metabolic disorders like gyrate atrophy, familial hypercholesterolemia, and phenylketonuria.
Conclusions:
- Gene therapy holds significant potential for treating genetic skin and metabolic diseases.
- Clinical trials using genetically modified keratinocytes are warranted.
- Further research is needed on efficient gene transfer to epidermal stem cells and immune response.